Vitamin B12 Deficiency: Common Questions and Answers.
Level 5 - mechanism / opinion, no new human data
Narrative clinical review without systematic review methodology
What was done
This narrative review summarizes diagnostic and management strategies for vitamin B12 deficiency, outlining risk factors, clinical features, laboratory diagnostic cutoffs, and oral versus intramuscular treatment pathways based on published clinical evidence.
What was found
Vitamin B12 deficiency affects approximately 2% to 3% of US adults. A total serum vitamin B12 level < 180 pg/mL is diagnostic, while borderline levels (180-350 pg/mL) warrant methylmalonic acid measurement to confirm deficiency if elevated. Oral supplementation is noninferior to intramuscular supplementation for most patients, with intramuscular reserved for severe deficiency or neurologic manifestations. Persistently elevated levels (> 1,000 pg/mL on two measurements) are associated with solid tumors, hematologic malignancy, and cardiovascular death.
Why it matters
It provides practical, evidence-based diagnostic thresholds and reassures clinicians that oral replacement is adequate for the majority of patients without severe neurologic symptoms.
Limits
The abstract describes a narrative review rather than a systematic review or primary trial. Exact treatment doses, specific outcome measures, and primary data details are not provided in the abstract.
Cited by
- supports Vitamin B12 deficiency can cause chronic fatigue-like syndromes.